# CivaTech Oncology

Source: https://onco.cc/companies/civatech-oncology/  
OnCo record `civatech-oncology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CivaTech Oncology is a United States-based medical device company running 2 late-stage cancer trials in pancreatic ductal adenocarcinoma and non-small-cell lung cancer.

## Summary

CivaTech Oncology, based in Research Triangle Park, Durham, NC, the United States, is a medical device company. CivaTech Oncology develops brachytherapy devices, including a flexible, bioabsorbable, polymer-encapsulated planar radiation source for treating solid tumours with minimal patient trauma. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in pancreatic ductal adenocarcinoma and non-small-cell lung cancer. The largest, NCT02843945 (Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source), plans to enrol 80 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Research Triangle Park, Durham, NC
- Type: devices
- Website: https://www.civatechoncology.com

## Sources

- Official website: https://www.civatechoncology.com
- ClinicalTrials.gov: trials led by CivaTech Oncology: https://clinicaltrials.gov/search?lead=CivaTech%20Oncology

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- trials: [Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®](https://onco.cc/trials/nct03290534/), [Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source](https://onco.cc/trials/nct02843945/)

---
JSON: https://onco.cc/api/v1/entities/civatech-oncology.json